Disease-specific composite measures for psoriatic arthritis are highly responsive to a Janus kinase inhibitor treatment that targets multiple domains of disease
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Coates, Laura C.
Soriano, Enrique R.
Elaine Husni, M.
Kanik, Keith S.
Funding for this research was provided by:
Pfizer Inc (N/A)